Angelia Denise Lockett

Title: Angelia Denise Lockett: Innovator in Pharmaceutical Research

Introduction

Angelia Denise Lockett is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of 2 patents, her work is paving the way for innovative treatments.

Latest Patents

Lockett's latest patents focus on nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. These compounds are designed to act as inhibitors of NAMPT, which plays a crucial role in various diseases, including pulmonary arterial hypertension (PAH). The patents detail methods for using these compounds to treat or prevent PAH, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Lockett has worked with esteemed institutions such as Indiana University and the University of Illinois. Her research has garnered attention for its potential impact on treating serious health conditions. Lockett's innovative approach and dedication to her work have established her as a respected figure in her field.

Collaborations

Some of her notable coworkers include Tom G Driver and Kira Ratia. Their collaborative efforts have contributed to the success of her research projects and the development of her patents.

Conclusion

Angelia Denise Lockett's contributions to pharmaceutical research through her innovative patents highlight her role as a leading inventor. Her work continues to inspire advancements in medical treatments, making a significant impact on healthcare.